Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Key International (BKYI) Cost of Revenue (2016 - 2025)

Bio Key International's Cost of Revenue history spans 16 years, with the latest figure at $357988.0 for Q3 2025.

  • For Q3 2025, Cost of Revenue fell 23.03% year-over-year to $357988.0; the TTM value through Sep 2025 reached $1.4 million, down 53.72%, while the annual FY2024 figure was $1.3 million, 79.61% down from the prior year.
  • Cost of Revenue for Q3 2025 was $357988.0 at Bio Key International, down from $464180.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.9 million in Q4 2023 and bottomed at $239569.0 in Q2 2021.
  • The 5-year median for Cost of Revenue is $393783.0 (2022), against an average of $675112.4.
  • The largest annual shift saw Cost of Revenue soared 516.95% in 2021 before it crashed 86.34% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $372051.0 in 2021, then skyrocketed by 164.59% to $984393.0 in 2022, then soared by 95.1% to $1.9 million in 2023, then plummeted by 86.34% to $262360.0 in 2024, then skyrocketed by 36.45% to $357988.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Cost of Revenue are $357988.0 (Q3 2025), $464180.0 (Q2 2025), and $279498.0 (Q1 2025).